Medtech grants in Norway
Explore Medtech grants for companies in Norway. This list brings together funding for medical devices, diagnostics, digital health and clinical validation from Norwegian innovation agencies, research funders and foundations, international programs open to applicants in Norway, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Medtech in Norway come first.
Showing 121-144 of 472 grants
Nutrition and Mental Health
πͺπΊEuropean Commission Β· European Union
Funds research linking diet and nutrients to mental health, aiming at evidence and guidance for policymakers and health professionals.
Optimising Advanced Therapy Medicinal Product (ATMP) Manufacturing
πͺπΊEuropean Commission Β· European Union
Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.
Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
πͺπΊIHI JU Β· European Union
Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.
Pollution's Impact on Brain Disease Development
πͺπΊEuropean Commission Β· European Union
Funds research proving the causal link between pollution exposure and neurological, neurodegenerative or neurodevelopmental disease, using biomarkers, imaging and long-term cohort data.
Post-Infection Long-Term Conditions Research
πͺπΊEuropean Commission Β· European Union
Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.
Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition
πͺπΊEuropean Commission Β· European Union
Funds pragmatic clinical trials testing tailored nutrition-based care to improve outcomes and quality of life for cancer patients aged 65 and older.
Preventing Harm From Digital Technology Use in Youth Mental Health
πͺπΊEuropean Commission Β· European Union
Funds research and digital interventions that curb the harm excessive or misguided technology use does to the mental health of children and young adults aged 15 to 24.
Regulatory Science for Patient-Centred Health Technologies
πͺπΊEuropean Commission Β· European Union
Funds research that updates the evidence and methods regulators use to assess medical devices, diagnostics and AI health tools, so safe innovations reach patients faster.
Research infrastructure services to enable R&I addressing main challenges and EU priorities
πͺπΊEuropean Commission Β· European Union
Funds transnational access to research infrastructure services in one of three areas β industrial biotechnology, radionuclide facilities, or climate prediction.
Research infrastructure services to enable R&I addressing main challenges and EU priorities related to the health domain
πͺπΊEuropean Commission Β· European Union
Funds transnational access to research infrastructure services for either epidemic-response research or paediatric clinical research, chosen as one area.
Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
πͺπΊIHI JU Β· European Union
Funds one project to build frameworks, guidance and recommendations that protect IP, trade secrets and regulatory data when health data is reused under the EHDS.
Scaling Up Cardiovascular Health Innovation (Strategic Agenda)
πͺπΊEuropean Commission Β· European Union
Funds one coordination project that maps existing cardiovascular research and builds a strategic research and innovation agenda for cutting cardiovascular disease across the EU.
Sex- and Gender-Specific Mechanisms of Cardiovascular Disease
πͺπΊEuropean Commission Β· European Union
Funds research into how biological sex and gender shape cardiovascular disease risk, aiming for tailored prevention, diagnosis and treatment models for women and men.
Space for Infrastructure: Health
π¦πΉESA Β· Global / Multinational
Funds studies and pilots for satellite-backed health-infrastructure services.
Space-Based Services and Applications Addressing COVID-19 Outbreak
π¦πΉESA Β· Global / Multinational
Co-funds satellite-based demonstration projects tackling COVID-19 healthcare and education needs.
SPIN: Rise
πͺπΊ28DIGITAL Β· European Union
Offers early-career deep-tech researchers a free venture-creation and pre-incubation programme with training, coaching and a European bootcamp.
SPRIND Continuous Hormone Monitoring Challenge β Stage 1
π©πͺSPRIND Β· Germany
Funds teams in Germany through a continuous hormone-monitoring challenge for advanced sensor development.
Support to the network of National Cancer Mission Hubs (NCMHs)
πͺπΊEuropean Commission Β· European Union
Funds coordination of national Cancer Mission Hubs across EU and associated countries to run policy dialogues, citizen engagement and knowledge-sharing on cancer.
Sustainable and healthy diets for cardiovascular diseases prevention with the support of digital applications
πͺπΊEuropean Commission Β· European Union
Funds SMEs and researchers building AI-backed digital tools that help people eat to prevent cardiovascular disease.
Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research
πͺπΊEuropean Commission Β· European Union
Funds a coordination action among national and regional cancer research funders to launch at least four joint transnational calls for translational cancer research.
Tackling Diarrhoeal Diseases in the Context of Climate and Health
πͺπΊEDCTP3 Β· European Union
Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.
Tackling High-Burden, Under-Researched Medical Conditions
πͺπΊEuropean Commission Β· European Union
Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.
THCS β Transforming Health and Care Systems (Access to Care)
π¦πΉANR Β· France
Funds French health and care consortia improving access-focused biomedical solutions.
Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction
πͺπΊIHI JU Β· European Union
Funds one large data platform that identifies shared biological markers for reward, motivation and impulsivity symptoms across Alzheimer's, depression, obesity and related disorders.